Studies were included if they were randomized controlled trials (RCTs) that compared hypertonic to isotonic crystalloid in patients with trauma or burns or in those undergoing surgery. Trials in both the out-of-hospital and hospital setting were included. Crossover trials were excluded. Trials of hypertonic crystalloid with an add-on colloid (eg, hypertonic saline solution and dextran) were not included. This comparison has been dealt with in a previous systematic review.
Cochrane Review. Studies included in the meta-analysis were identified by searching MEDLINE, EMBASE, the Cochrane Controlled Trials Register, the Cochrane Injuries Group Specialized Register, and the National Research Register. The reviewers checked reference lists of all articles identified for additional trials. The review is updated to November 2001.
S T U D Y S E L E C T I O N
Studies were included if they were randomized controlled trials (RCTs) that compared hypertonic to isotonic crystalloid in patients with trauma or burns or in those undergoing surgery. Trials in both the out-of-hospital and hospital setting were included. Crossover trials were excluded. Trials of hypertonic crystalloid with an add-on colloid (eg, hypertonic saline solution and dextran) were not included. This comparison has been dealt with in a previous systematic review.
D A T A E X T R A C T I O N
Two authors independently extracted the data and assessed the quality of the trials. The principal outcome measures were mortality from all causes and disability assessed at follow-up using the Glasgow Outcome Scale. For each trial, the relative risk (RR) of death and 95% confidence intervals (CIs) were calculated. Subgroup analyses were conducted of trials using comparable volumes and trials using comparable resuscitation end points. The Annals' EBEM editors prepared the abstract of this Cochrane systematic review as well as the EvidenceBased Medicine Teaching Points.
O B J E C T I V E
To determine if hypertonic crystalloid replacement therapy is more effective than isotonic crystalloid in the resuscitation of patients with trauma or burns or in those undergoing surgery.
D A T A S O U R C E S
This systematic review was published in the software version of the surgery) were included in this review. Concealment of allocation was clear in 5 trials and inadequate in 2. Data on death were obtained in 12 studies. Only 1 trial reported data on disability.
The pooled RR for death was 0.84 (95% CI 0.61 to 1.16) in trauma patients, 1.49 (95% CI 0.56 to 3.95) in patients with burns, and 0.62 (95% CI 0.08 to 4.57) in patients undergoing surgery. In the 1 trial using the Glasgow Outcome Scale, the RR was 0.99 (95% CI 0.06 to 15.93). The RR for death in the trials that used comparative volumes (n=6) was 0.90 (95% CI 0.64 to 1.27) versus 0.85 (95% CI 0.46 to 1.59) in trials using comparative end points (n=10). The RR for death in the out-of-hospital trials was 0.78 (95% CI 0.53 to 1.15) versus 1.04 (95% CI 0.65 to 1.68) in in-hospital trials.
C O N C L U S I O N S
The authors conclude that there are insufficient data to conclude that hypertonic crystalloid is better than isotonic crystalloid for the resuscitation of patients with trauma or burns or in those undergoing surgery. However, the CIs are very wide, which means that clinically important differences may exist. Further large trials that compare hypertonic to isotonic crystalloid to detect a clinically important difference are needed. 
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C O M M E N T A R Y : C L I N I C A L I M P L I C A T I O N
Hypertonic saline (HTS) solution is thought to restore hemodynamics by attempt to address the controversy in regard to fluids versus no fluids in hypovolemic shock. 2 
T A K E H O M E M E S S A G E
There are insufficient data to conclude hypertonic crystalloid is better than isotonic crystalloid for the resuscitation of patients with trauma or burns or in those undergoing surgery. 
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E V I D E N C E -B A S E D M E D I C I N E T E A C H I N G P O I N T S
Relative risk. A relative risk (RR) of less than 1.0 indicates a protective effect of hypertonic crystalloid. A RR of more than 1.0 indicates treatment with isotonic crystalloid is better. Ninety-five percent CIs that include 1.0 are not significant and indicate no difference between the treatments.
Allocation concealment. Randomization is concealed when the study participants and investigators are unaware of the group assignment (eg, to treatment or control). Many articles do not report concealment of allocation, although it is now part of the CONSORT reporting guidelines. Studies that do not conceal the allocation tend to inflate the estimation of the treatment effect.
causing an osmotic fluid shift from the intracellular to the extracellular compartment. Animal studies using a controlled hemorrhage model have demonstrated an increase in blood pressure and circulating volume with HTS solution resuscitation. 1 However, studies using an uncontrolled hemorrhage model have shown higher mortality rates with HTS solution compared with isotonic saline solution. 1 It is hypothesized that by rapidly increasing the blood pressure, HTS solution resuscitation results in increased hemorrhage volume. The uncontrolled hemorrhage model is thought to best represent the trauma victim with continued bleeding, such as those in the out-of-hospital setting.
The main hypothesis of this systematic review was clearly stated: HTS solution decreases mortality in patients with hypovolemia with and without head injuries. The authors performed a comprehensive search for published RCTs. However, no attempt was made to identify unpublished studies. The selection criteria were well defined, and subgroups were specified a priori. The reviewers were unable to adequately assess the effects of HTS resuscitation in head-injured patients because only one small study focused on this patient population.
One of the most interesting aspects of this systematic review for emergency medicine is the subgroup analysis based on those studies providing fluids in the out-of-hospital phase. The 2 studies in this subgroup were given the highest methodologic quality rating. Although not reaching statistical significance, examination of the 95% CI reveals a trend toward benefit. The CI could be expected to narrow with larger clinical trials. Until such trials are completed, there is insufficient evidence to support the use of HTS solution in the trauma or burn victim. A future meta-analysis will
